Enova unit OnDeck launches automated final-decisioning for small business loans
Bitget2026/10/08 12:34OnDeck, part of Enova International, launched automated final-decisioning for small business loan applications using AI-enabled verification. Real-time decisioning targets cutting funding decisions from a few hours to under a minute for qualifying applicants. Capability expands from eligible existing customers to new applicants across channels, aiming to shift more originations to automated decisions. Approvals can be stipulation-free, letting eligible borrowers move straight to funding without additional documents. Automated decisions remain subject to OnDeck’s existing underwriting standards and ongoing model performance monitoring. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enova International Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CG66601) on October 08, 2026, and is solely responsible for the information contained therein.
- OnDeck, part of Enova International, launched automated final-decisioning for small business loan applications using AI-enabled verification.
- Real-time decisioning targets cutting funding decisions from a few hours to under a minute for qualifying applicants.
- Capability expands from eligible existing customers to new applicants across channels, aiming to shift more originations to automated decisions.
- Approvals can be stipulation-free, letting eligible borrowers move straight to funding without additional documents.
- Automated decisions remain subject to OnDeck’s existing underwriting standards and ongoing model performance monitoring.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
